Johnson & Johnson (JNJ) Capital Expenditures (2009 - 2026)

Johnson & Johnson's Capital Expenditures history runs 18 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Capital Expenditures rose 31.95% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $5.1 billion (up 15.28% YoY), while the FY2025 annual figure was $4.8 billion, up 9.22% from the prior year.
• Capital Expenditures came in at $1.0 billion for Q1 2026 at Johnson & Johnson, down from $1.8 billion in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.8 billion in Q4 2025 to a low of $607.0 million in Q2 2022.
• A 5-year average of $1.1 billion and a median of $1.0 billion in 2025 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures surged 42.17% in 2023 and retreated 13.17% in 2024, its largest moves.
• Johnson & Johnson's Capital Expenditures stood at $607.0 million in 2022, then surged by 161.78% to $1.6 billion in 2023, then gained by 1.45% to $1.6 billion in 2024, then gained by 13.96% to $1.8 billion in 2025, then tumbled by 42.9% to $1.0 billion in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $1.0 billion, $1.8 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison